These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
206 results:

  • 1. Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer.
    Moll GN
    Eur J Pharmacol; 2024 Sep; 978():176772. PubMed ID: 38925290
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis.
    Ma Z; Sun Y; Yu Y; Xiao W; Xiao Z; Zhong T; Xiang X; Li Z
    Cell Commun Signal; 2024 May; 22(1):295. PubMed ID: 38802814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
    Zeng T; Ling C; Liang Y
    Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
    Stany B; Mishra S; Rao KVB
    Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells.
    Mathur S; Srivastava P; Srivastava A; Rai NK; Abbas S; Kumar A; Tiwari M; Sharma LK
    BMC Cancer; 2024 Mar; 24(1):323. PubMed ID: 38459456
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
    Kim J; Koh DI; Lee M; Park YS; Hong SW; Shin JS; Lee MS; Kim MH; Lee JH; Jeong J; Bae S; Hong JK; Jeong HR; Ryu YS; Kim SM; Choi M; Kim H; Ryu H; Hur SC; Park J; Hur DY; Jin DH
    Cell Death Differ; 2023 Dec; 30(12):2491-2507. PubMed ID: 37926711
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Network pharmacology-based anti-colorectal cancer activity of piperlonguminine in the ethanolic root extract of Piper longum L.
    Singh I; Das R; Kumar A
    Med Oncol; 2023 Oct; 40(11):320. PubMed ID: 37796360
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
    Beekhof R; Bertotti A; Böttger F; Vurchio V; Cottino F; Zanella ER; Migliardi G; Viviani M; Grassi E; Lupo B; Henneman AA; Knol JC; Pham TV; de Goeij-de Haas R; Piersma SR; Labots M; Verheul HMW; Trusolino L; Jimenez CR
    Sci Transl Med; 2023 Aug; 15(709):eabm3687. PubMed ID: 37585503
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
    Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of colorectal cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of ALCAM in Clinical Colon cancer and Relationship With Patients' treatment Responses.
    Fang Z; Zeng JJ; Yang Y; Ruge F; Lane J; Hargest R; Jiang WG
    In Vivo; 2023; 37(3):1117-1128. PubMed ID: 37103072
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. src-FAK Signaling Mediates Interleukin 6-Induced HCT116 colorectal cancer Epithelial-Mesenchymal Transition.
    Huang YH; Chen HK; Hsu YF; Chen HC; Chuang CH; Huang SW; Hsu MJ
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PRPF19 facilitates colorectal cancer liver metastasis through activation of the src-YAP1 pathway via K63-linked ubiquitination of MYL9.
    Zhou R; Chen J; Xu Y; Ye Y; Zhong G; Chen T; Qiu L
    Cell Death Dis; 2023 Apr; 14(4):258. PubMed ID: 37031206
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combining MEK and src inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.
    Fan F; Ghosh S; Powell R; Roszik J; Park Y; Sobieski M; Sorokin A; Stephan C; Kopetz S; Ellis LM; Bhattacharya R
    PLoS One; 2023; 18(3):e0281063. PubMed ID: 36952536
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A reversible src-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF
    Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
    Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis.
    Fatima I; Uppada JP; Chhonker YS; Gowrikumar S; Barman S; Roy S; Tolentino KT; Palermo N; Natarajan A; Beauchamp DR; Vecchio A; Murry DJ; Singh AB; Hopkins CR; Dhawan P
    Biomed Pharmacother; 2023 Mar; 159():114255. PubMed ID: 36696800
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis.
    Li Y; Zhou H; Liu P; Lv D; Shi Y; Tang B; Xu J; Zhong T; Xu W; Zhang J; Zhou J; Ying K; Zhao Y; Sun Y; Jiang Z; Cheng H; Zhang X; Ke Y
    J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36626230
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anti-cancer Effects of a New Herbal Medicine PSY by Inhibiting the STAT3 Signaling Pathway in colorectal cancer Cells and Its Phytochemical Analysis.
    Han S; Kim H; Lee MY; Lee J; Ahn KS; Ha IJ; Lee SG
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499154
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.